Get 20% lifetime commission for referring investors to digrin.com
here.
Arcturus Therapeutics Holdings Inc. ( ARCT) - Key Metrics
ARCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.10 | -$0.84 | -$0.70 | -$0.70 |
| 2026Q1 | $0.02 | -$0.95 | -$0.68 | -$0.68 |
| 2025Q4 | $0.11 | -$1.06 | -$0.59 | -$0.60 |
| 2025Q3 | $0.63 | -$0.49 | -$0.63 | -$0.64 |
| 2025Q2 | $0.90 | -$0.34 | -$0.21 | -$0.21 |
ARCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2 |
| 2026Q1 | 0% | -2.03 |
| 2025Q4 | 0% | -1.46 |
| 2025Q3 | 0% | -9.40 |
| 2025Q2 | 0% | -9.57 |
ARCT
Price: $8.21
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.33 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 359653
Ebitda: -2.9 millionMarket Capitalization: 214.3 million